Company Directory > Biotech > Ajou University
Ajou University is a leading research-oriented university in South Korea, particularly recognized for its strong focus on engineering, medicine, and pharmaceutical sciences. Located in Suwon, the university operates a comprehensive medical and biotech ecosystem that includes the Ajou University Hospital, the College of Pharmacy, and the School of Medicine. It is a major hub for clinical research and drug development in the Gyeonggi province, benefiting from its proximity to a cluster of leading pharmaceutical firms and research centers. The university is highly active in technology commercialization, consistently ranking among the top Korean universities for technology transfer revenue. Its research infrastructure supports a wide range of therapeutic areas, including oncology, immunology, and CNS disorders. Ajou University has successfully spun off several biotech ventures, such as Genesen and S&K Therapeutics, which focus on peptide-based drugs and small molecule inhibitors for inflammatory and autoimmune diseases.
CLASSIFICATION
Company Type:Biotech
Industry:Biotechnology
Sub-Industry:Academic Research & Drug Discovery
SIZE & FINANCIALS
Employees:10000+
Revenue:$100M-$500M
Founded:1973
Ownership:nonprofit
Status:operating
FUNDING
Stage:government_funded
Total Raised:$50M+
Investors:Ministry of Education (South Korea), National Research Foundation of Korea, Korean Intellectual Property Office (KIPO)
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (Collaborative/Investigator-initiated)
Modalities:Small molecule, Peptide, Cell therapy, mAb, Gene therapy, AI-driven drug discovery
Active Trials:397
Trial Phases:Phase 1: 45 | Phase 2: 30 | Phase 3: 15 | Phase 4: 10
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Daewoo Educational Foundation
Subsidiaries:Ajou University Hospital, Ajou University Industry-Academic Cooperation Foundation, N4U Tech Holdings Inc., Genesen (Spin-off), S&K Therapeutics (Spin-off)
Key Partnerships:Syntekabio (AI-driven drug discovery), Wizbiosolutions (POCT and digital bio), SK Ecoplant (Severe trauma care infrastructure), GC Biopharma (Clinical trial collaborations)
COMPETITION
Position:Leader
Competitors:Seoul National University, KAIST, Yonsei University, Korea University, Sungkyunkwan University
LEADERSHIP
Key Executives:
Choi Ki-joo - President
Bong-Jin Lee - Dean, College of Pharmacy
Scientific Founders:Choi Sang-dun (Professor / CEO of S&K Therapeutics)
Board Members:Kim Sun-yong (Chairman, Daewoo Academy)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ajou University. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.